Clinical Trial Update: Phase 2 Trial of HY209gel in Atopic Dermatitis Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial update for HY209gel in atopic dermatitis shows the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• HY209gel

Snippet

Sponsor: Shaperon | Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Status: ACTIVE_NOT_RECRUITING